Melanotan II (commonly abbreviated as MT-2) is a synthetic peptide analog of alpha-melanocyte stimulating hormone. It is composed of a short sequence of modified amino acids designed to bind to melanocortin receptors in experimental models. The compound was originally developed in laboratory settings to assist researchers studying pigmentation pathways and receptor-mediated cellular signaling.

Unlike naturally occurring hormones, Melanotan II contains structural alterations that improve stability and resistance to enzymatic breakdown, making it more suitable for controlled investigations. Most scientific work with MT-2 has focused on its interaction with MC1R and related receptors that regulate melanin production within skin cells.

Available preclinical and in-vitro data suggests Melanotan II may be useful for research examining:

• Regulation of melanogenesis in epidermal melanocytes
• Melanocortin receptor binding affinity and signaling cascades
• Dose-response relationships in pigment formation
• Photoprotection mechanisms linked to increased melanin
• Peptide stability under various storage conditions

Melanotan II has become widely utilized among private laboratories conducting exploratory research into cosmetic-related biological processes. All material supplied as MT-2 is intended strictly for investigational purposes and must be handled using appropriate laboratory protocols.

Intended Use: Product supplied strictly as an investigational research compound. It is not approved by the FDA, TGA, or any regulatory authority for therapeutic, diagnostic, or medicinal use. Not for human or animal consumption.